The decision to create the International Patient Organisation for ...

The decision to create the International Patient Organisation for Primary Immunodeficiencies (IPOPI) emanates from an interim organising committee that met in Oxford, UK, in 1990. Two years later, IPOPI was formally established in Lugano, Switzerland. The small group of representatives from the primary immunodeficiency community (PID) who met in 1990 identified the need to start an organisation that provides international representation and support to national PID patient groups around the world. IPOPI’s mission is to improve awareness and access to early diagnosis and optimal treatments for PID patients worldwide.

IPOPI

[YOUR MESSAGE]%0D%0A%0D%0A%0D%0ALocation: ${location}%0D%0A%0D%0AReport:%0D%0A${report}

black (do not use in pages!!)

white (do not use in pages!!)

octaBlue (do not use in pages!!)

azure

green

orange

rose

turquoise

umbra

yellow

atenativ

octaplasLG

albunorm

fibryga

octaplex

gammanorm

cutaquiq

reshonativ

octagam

panzyga

nuwiq

octanineF

wilate

octanate

IPOPI

Tietoa Octapharmasta

Valmisteet